354 related articles for article (PubMed ID: 15231860)
1. A preliminary study of preoperative chemotherapy combining irinotecan and cisplatin in patients with gastric cancer with unresectable para-aortic lymph node metastases.
Yamao T; Ohta K; Ohyama S; Ishihara S; Chin K; Maruyama M; Takahashi T; Nakajima T
Jpn J Clin Oncol; 2004 May; 34(5):255-61. PubMed ID: 15231860
[TBL] [Abstract][Full Text] [Related]
2. Neoadjuvant chemotherapy with CPT-11 and cisplatin downstages locally advanced gastric cancer.
Newman E; Marcus SG; Potmesil M; Sewak S; Yee H; Sorich J; Hayek M; Muggia F; Hochster H
J Gastrointest Surg; 2002; 6(2):212-23; discussion 223. PubMed ID: 11992807
[TBL] [Abstract][Full Text] [Related]
3. Neoadjuvant chemotherapy with S-1 and cisplatin followed by D2 gastrectomy with para-aortic lymph node dissection for gastric cancer with extensive lymph node metastasis.
Tsuburaya A; Mizusawa J; Tanaka Y; Fukushima N; Nashimoto A; Sasako M;
Br J Surg; 2014 May; 101(6):653-60. PubMed ID: 24668391
[TBL] [Abstract][Full Text] [Related]
4. A phase II study of preoperative chemotherapy with docetaxel, cisplatin, and S-1 followed by gastrectomy with D2 plus para-aortic lymph node dissection for gastric cancer with extensive lymph node metastasis: JCOG1002.
Ito S; Sano T; Mizusawa J; Takahari D; Katayama H; Katai H; Kawashima Y; Kinoshita T; Terashima M; Nashimoto A; Nakamori M; Onaya H; Sasako M
Gastric Cancer; 2017 Mar; 20(2):322-331. PubMed ID: 27299887
[TBL] [Abstract][Full Text] [Related]
5. [A case of advanced gastric cancer successfully treated with TS-1/CDDP combination chemotherapy, able to maintain CR for more than two years against multiple liver metastases].
Meguro E; Kimura T; Noda Y; Matsumoto Y; Irinoda T; Hayakawa Y; Kobayashi M; Takagane A; Hioki J
Gan To Kagaku Ryoho; 2007 Feb; 34(2):249-52. PubMed ID: 17301537
[TBL] [Abstract][Full Text] [Related]
6. [A case of peritoneal dissemination of gastric cancer successfully treated by irinotecan combined with cisplatin].
Masaki K; Nomura M; Inoue Y; Fujita S; Sakao J; Hirota M; Souda S
Gan To Kagaku Ryoho; 2005 Jun; 32(6):851-4. PubMed ID: 15984530
[TBL] [Abstract][Full Text] [Related]
7. Feasibility and efficacy of preoperative chemotherapy with docetaxel, cisplatin and S-1 in gastric cancer patients with para-aortic lymph node metastases.
Fushida S; Fujimura T; Oyama K; Yagi Y; Kinoshita J; Ohta T
Anticancer Drugs; 2009 Sep; 20(8):752-6. PubMed ID: 19543076
[TBL] [Abstract][Full Text] [Related]
8. [A case of advanced gastric cancer effectively treated by combined chemotherapy of paclitaxel (TXL) and CDDP].
Nagata N; Inoue Y; Fukushima M; Shibao K; Tsurudome Y; Higure A; Hirata K; Nakayama Y; Okamoto K; Konishi T; Itoh H
Gan To Kagaku Ryoho; 2004 Apr; 31(4):585-8. PubMed ID: 15114704
[TBL] [Abstract][Full Text] [Related]
9. [A case of multiple distant lymph node metastases from advanced gastric cancer treated with adjuvant chemotherapy after total gastrectomy].
Haruki S; Usui S; Takiguchi N; Arita K; Ito K; Matsumoto A; Hiranuma S; Suzuki K
Gan To Kagaku Ryoho; 2013 Nov; 40(12):2274-6. PubMed ID: 24394083
[TBL] [Abstract][Full Text] [Related]
10. A phase II study of irinotecan with biweekly, low dose leucovorin and bolus and continuous infusion 5-fluorouracil (modified FOLFIRI) as first line therapy for patients with recurrent or metastatic gastric cancer.
Kim BG; Oh SY; Kwon HC; Lee S; Lee DM; Kim SG; Kim DK; Jang JS; Kim MC; Kim SH; Kim HJ
Am J Clin Oncol; 2010 Jun; 33(3):246-50. PubMed ID: 19770628
[TBL] [Abstract][Full Text] [Related]
11. Phase II study of neoadjuvant chemotherapy and extended surgery for locally advanced gastric cancer.
Yoshikawa T; Sasako M; Yamamoto S; Sano T; Imamura H; Fujitani K; Oshita H; Ito S; Kawashima Y; Fukushima N
Br J Surg; 2009 Sep; 96(9):1015-22. PubMed ID: 19644974
[TBL] [Abstract][Full Text] [Related]
12. Phase II trial of preoperative irinotecan-cisplatin followed by concurrent irinotecan-cisplatin and radiotherapy for resectable locally advanced gastric and esophagogastric junction adenocarcinoma.
Rivera F; Galán M; Tabernero J; Cervantes A; Vega-Villegas ME; Gallego J; Laquente B; Rodríguez E; Carrato A; Escudero P; Massutí B; Alonso-Orduña V; Cardenal A; Sáenz A; Giralt J; Yuste AL; Antón A; Aranda E;
Int J Radiat Oncol Biol Phys; 2009 Dec; 75(5):1430-6. PubMed ID: 19540072
[TBL] [Abstract][Full Text] [Related]
13. [A case of curatively resected AFP producing gastric cancer with massive lymph node metastasis effectively treated by neoadjuvant-chemotherapy of S-1 and CDDP].
Mimatsu K; Kawasaki A; Oida T; Aramaki O; Kuboi Y; Kano H; Ogura M; Amano S
Gan To Kagaku Ryoho; 2007 Aug; 34(8):1279-82. PubMed ID: 17687213
[TBL] [Abstract][Full Text] [Related]
14. Combination chemotherapy with irinotecan and cisplatin in pretreated patients with unresectable or recurrent gastric cancer.
Ueda S; Hironaka S; Boku N; Fukutomi A; Yoshino T; Onozawa Y
Gastric Cancer; 2006; 9(3):203-7. PubMed ID: 16952039
[TBL] [Abstract][Full Text] [Related]
15. [A clinical case of lymph node recurrence after resection of gastric cancer successfully treated by combination chemotherapy with irinotecan and cisplatin].
Fukunaga H; Endo W; Fujie Y; Shimizu K; Toyoda Y; Yoshioka A; Yoshioka S; Hojou S; Ota H; Maeura Y
Gan To Kagaku Ryoho; 2010 Nov; 37(12):2418-20. PubMed ID: 21224592
[TBL] [Abstract][Full Text] [Related]
16. A pilot study of an individualized comprehensive treatment for advanced gastric cancer with para-aortic lymph node metastasis.
He Q; Ma L; Li Y; Li G
BMC Gastroenterol; 2016 Jan; 16():8. PubMed ID: 26782354
[TBL] [Abstract][Full Text] [Related]
17. Irinotecan (CPT-11) and mitomycin-C (MMC) as second-line therapy in advanced gastric cancer: a phase II study of the Gruppo Oncologico dell' Italia Meridionale (prot. 2106).
Giuliani F; Molica S; Maiello E; Battaglia C; Gebbia V; Di Bisceglie M; Vinciarelli G; Gebbia N; Colucci G;
Am J Clin Oncol; 2005 Dec; 28(6):581-5. PubMed ID: 16317268
[TBL] [Abstract][Full Text] [Related]
18. [A case of advanced gastric cancer with abdominal paraaortic lymph node swelling successfully resected following neoadjuvant chemotherapy of TS-1 and low-dose cisplatin].
Morifuji M; Murakami Y; Yokoyama T; Yokoyama Y; Kanehiro T; Uemura K; Sasaki M; Sueda T
Gan To Kagaku Ryoho; 2003 May; 30(5):711-5. PubMed ID: 12795108
[TBL] [Abstract][Full Text] [Related]
19. Phase II study of a combination of irinotecan and cisplatin against metastatic gastric cancer.
Boku N; Ohtsu A; Shimada Y; Shirao K; Seki S; Saito H; Sakata Y; Hyodo I
J Clin Oncol; 1999 Jan; 17(1):319-23. PubMed ID: 10458249
[TBL] [Abstract][Full Text] [Related]
20. Neoadjuvant chemotherapy combining docetaxel, cisplatin and S-1 in gastric cancer with para-aortic lymph node metastases: report of five cases.
Fushida S; Fujimura T; Oyama K; Kinoshita J; Fujita H; Ninomiya I; Ohta T
Hepatogastroenterology; 2010; 57(104):1650-4. PubMed ID: 21443137
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
